These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33740286)

  • 41. Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength.
    Sinder BP; White LE; Salemi JD; Ominsky MS; Caird MS; Marini JC; Kozloff KM
    Osteoporos Int; 2014 Aug; 25(8):2097-107. PubMed ID: 24803333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
    Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
    Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Curative Cell and Gene Therapy for Osteogenesis Imperfecta.
    Schindeler A; Lee LR; O'Donohue AK; Ginn SL; Munns CF
    J Bone Miner Res; 2022 May; 37(5):826-836. PubMed ID: 35306687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age.
    Sinder BP; Lloyd WR; Salemi JD; Marini JC; Caird MS; Morris MD; Kozloff KM
    Bone; 2016 Mar; 84():222-229. PubMed ID: 26769006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Material and nanomechanical properties of bone structural units of cortical and trabecular iliac bone tissues from untreated postmenopausal osteoporotic women.
    Farlay D; Falgayrac G; Ponçon C; Rizzo S; Cortet B; Chapurlat R; Penel G; Badoud I; Ammann P; Boivin G
    Bone Rep; 2022 Dec; 17():101623. PubMed ID: 36213624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Widespread disturbance in extracellular matrix collagen biomarker responses to teriparatide therapy in osteogenesis imperfecta.
    Nicol L; Srikanth P; Henriksen K; Sun S; Smith R; Karsdal MA; Nagamani SCS; Shapiro J; Lee B; Leder BZ; Orwoll E
    Bone; 2021 Jan; 142():115703. PubMed ID: 33099032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotypic Spectrum in Osteogenesis Imperfecta Due to Mutations in TMEM38B: Unraveling a Complex Cellular Defect.
    Webb EA; Balasubramanian M; Fratzl-Zelman N; Cabral WA; Titheradge H; Alsaedi A; Saraff V; Vogt J; Cole T; Stewart S; Crabtree NJ; Sargent BM; Gamsjaeger S; Paschalis EP; Roschger P; Klaushofer K; Shaw NJ; Marini JC; Högler W
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2019-2028. PubMed ID: 28323974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between vitamin D status and bone mineralization, mass, and metabolism in children with osteogenesis imperfecta: histomorphometric study.
    Edouard T; Glorieux FH; Rauch F
    J Bone Miner Res; 2011 Sep; 26(9):2245-51. PubMed ID: 21544864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of bone architecture using fractal-based TX-Analyzer™ in adult patients with osteogenesis imperfecta.
    Schanda JE; Huber S; Behanova M; Haschka J; Kraus DA; Meier P; Bahrami A; Zandieh S; Muschitz C; Resch H; Mähr M; Rötzer K; Uyanik G; Zwerina J; Kocijan R
    Bone; 2021 Jun; 147():115915. PubMed ID: 33722771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum Sclerostin Levels in Adults With Osteogenesis Imperfecta: Comparison With Normal Individuals and Response to Teriparatide Therapy.
    Nicol L; Wang Y; Smith R; Sloan J; Nagamani SC; Shapiro J; Lee B; Orwoll E
    J Bone Miner Res; 2018 Feb; 33(2):307-315. PubMed ID: 29044725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type I assessed by high-resolution pQCT.
    Folkestad L; Hald JD; Hansen S; Gram J; Langdahl B; Abrahamsen B; Brixen K
    J Bone Miner Res; 2012 Jun; 27(6):1405-12. PubMed ID: 22407910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of novel raloxifene analogs alone or in combination with mechanical loading in the Col1a2
    Kohler R; Creecy A; Williams DR; Allen MR; Wallace JM
    Bone; 2024 Feb; 179():116970. PubMed ID: 37977416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
    Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
    Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fracture Healing in Collagen-Related Preclinical Models of Osteogenesis Imperfecta.
    Zieba J; Munivez E; Castellon A; Jiang MM; Dawson B; Ambrose CG; Lee B
    J Bone Miner Res; 2020 Jun; 35(6):1132-1148. PubMed ID: 32053224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta.
    Roschger A; Roschger P; Keplingter P; Klaushofer K; Abdullah S; Kneissel M; Rauch F
    Bone; 2014 Sep; 66():182-8. PubMed ID: 24953712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel transgenic murine model with persistently brittle bones simulating osteogenesis imperfecta type I.
    Liu Y; Wang J; Liu S; Kuang M; Jing Y; Zhao Y; Wang Z; Li G
    Bone; 2019 Oct; 127():646-655. PubMed ID: 31369917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Baseline Measurement of Quality of Life in 322 Adults With Osteogenesis Imperfecta.
    Gooijer K; Harsevoort AGJ; van Dijk FS; Withaar HR; Janus GJM; Franken AAM
    JBMR Plus; 2020 Dec; 4(12):e10416. PubMed ID: 33354642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteogenesis imperfecta: bone turnover, bone density, and ultrasound parameters.
    Cepollaro C; Gonnelli S; Pondrelli C; Montagnani A; Martini S; Bruni D; Gennari C
    Calcif Tissue Int; 1999 Aug; 65(2):129-32. PubMed ID: 10430645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fkbp10 Deletion in Osteoblasts Leads to Qualitative Defects in Bone.
    Lietman CD; Lim J; Grafe I; Chen Y; Ding H; Bi X; Ambrose CG; Fratzl-Zelman N; Roschger P; Klaushofer K; Wagermaier W; Schmidt I; Fratzl P; Rai J; Weis M; Eyre D; Keene DR; Krakow D; Lee BH
    J Bone Miner Res; 2017 Jun; 32(6):1354-1367. PubMed ID: 28206698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perturbations in fatty acid metabolism and collagen production infer pathogenicity of a novel
    Lim PJ; Marcionelli G; Srikanthan P; Ndarugendamwo T; Pinner J; Rohrbach M; Giunta C
    Front Endocrinol (Lausanne); 2023; 14():1195704. PubMed ID: 37305034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.